AGE Reader™ is the first and only diagnostic device that non-invasively diagnose and assess the risk of diabetes and its cardiovascular, nephrological and neurological complications through measuring tissue accumulation of AGEs.
Powered by its proprietary technologies, this revolutionary device is a novel tool to researchers and clinicians and its arrival marks the new horizon in AGEs' detection and risk assessment on cardiovascular diseases, diabetes and renal failure. It is:
